M
Mario Boccadoro
Researcher at University of Turin
Publications - 670
Citations - 39049
Mario Boccadoro is an academic researcher from University of Turin. The author has contributed to research in topics: Multiple myeloma & Lenalidomide. The author has an hindex of 83, co-authored 638 publications receiving 34589 citations. Previous affiliations of Mario Boccadoro include Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter Study
Massimo Gentile,Stefania Ciolli,Maria Teresa Petrucci,Sara Galimberti,Giuseppe Mele,Antonio Francesco Casulli,Donato Mannina,Eugenio Piro,Graziella Pinotti,Salvatore Palmieri,Lucio Catalano,Vincenzo Callea,Massimo Offidani,Pellegrino Musto,Sara Bringhen,Luca Baldini,Patrizia Tosi,Francesco Di Raimondo,Mario Boccadoro,Antonio Palumbo,Michele Cavo,Fortunato Morabito +21 more
TL;DR: Vel, either as single agent or combined with other drugs, has been shown to be highly active in MM pts with varying degrees of RI, and retrospectively analyzed the outcome of 105 pts with RI.
Journal ArticleDOI
Early B lymphocytes in man.
TL;DR: It is confirmed in man the presence of a subpopulation of B lymphocytes which cannot reexpress their immunological receptors after challenge with antibodies.
Journal ArticleDOI
Immunophenotypic response after allografting in multiple myeloma
Lucia Brunello,Roberto Passera,Moreno Festuccia,Milena Gilestro,Enrico Maffini,Federica Ferrando,Mario Boccadoro,Paola Omedè,Benedetto Bruno +8 more
TL;DR: The achievement of IR confers a favorable impact on OS and EFS after allografting, and a higher incidence of extra-medullary in the noCR/IR group (some 30% of the patient cohort) may suggest that myeloma cells escape immune control outside the bone marrow.
Journal ArticleDOI
Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study
Saad Z. Usmani,Vania Hungria,Xavier Leleu,Hans C. Lee,Faith E. Davies,Caitlin Costello,Robert M. Rifkin,Katja Weisel,Ajai Chari,Noemi Puig,Mario Boccadoro,Gordon Cook,Jesus G. Berdeja,Jeffrey A. Zonder,Michael A. Thompson,Rafat Abonour,Jorge Vela-Ojeda,Roman Hájek,Andrew Spencer,Jim Omel,Brittany Demers,Dorothy Romanus,Kaili Ren,Tomas Skacel,Dawn Marie Stull,Evangelos Terpos +25 more
TL;DR: The INSIGHT MM as discussed by the authors study is the largest global prospective observational observational study of NDMM and relapsed/refractory MM patients, which was conducted from July 1, 2016 to April 27, 2018.
Journal ArticleDOI
Early disappearance of murine plasmocytoma stem cells in long-term bone marrow culture.
Corrado Tarella,Paola Omedè,Mario Boccadoro,Antonio Palumbo,Silvano Battaglio,Alessandro Pileri +5 more
TL;DR: The results suggest the efficacy of the LTBMC for the in vitro elimination of myeloma cells, including the neoplastic stem cells.